Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

AGNGvsIHEETF Comparison

ETF 1
AGNG

Global X Aging Population ETF

This fund is part of
New Consumers & Focus
+1.22%
VS
ETF 2
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-0.7%

Global X Aging Population ETF (AGNG) belongs to the New Consumers & Focus segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. AGNG's top 3 sector exposures are Healthcare, Finance and Technology. In contrast, IHE's top sector exposures are Healthcare, Non-Corporate  AGNG is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.38% for IHE. AGNG is up 4.95% year-to-date (YTD) with +$13M in YTD flows. IHE performs better with 21.57% YTD performance, and +$603M in YTD flows. Run a side-by-side ETF comparison of AGNG and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

AGNG vs IHE performance and flow charts

Performance

-1.00.01.02.03.04.05.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

0 M100 M200 M300 M400 M500 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
AGNG
IHE
+4.11%+3.46%
+7.07%+17.24%
+4.95%+21.57%
+16.31%+55.04%
+37.15%+77.18%
+28.43%+74.71%
Flows
AGNG
IHE
-+$486M
+$692K+$535M
+$13M+$603M
+$18M+$757M
+$23M+$852M
+$13M+$867M
Volatility and drawdown
3M1Y3Y5Y
Volatility
AGNG
IHE
+14.86%+20.30%
+13.13%+18.02%
+12.28%+16.91%
+13.80%+16.50%
Max drawdown
AGNG
IHE
-4.89%-4.42%
-11.18%-8.48%
-13.73%-16.04%
-25.40%-16.12%
Max drawdown duration
AGNG
IHE
31d20d
151d81d
323d210d
1041d669d
Trading data

Create an account to view trading data

Join for free
AGNG
IHE
Last sale
7/30/2026 at 7:58 PM
$37.50
$101.47
Previous close
07/30/2026
$37.82
$102.46
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
AGNG
IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/30/2026 at 7:58 PM
Live
Closed
AGNG
IHE
Last price
$37.50
$101.47
1D performance
-0.83%
-0.97%
AuM$87.98 M$1.64 B
E/R0.5%0.38%
Characteristics
AGNG
IHE
Management strategyPassivePassive
ProviderGlobal XiShares
BenchmarkIndxx Aging Population Thematic IndexDow Jones U.S. Select Pharmaceuticals Index
N° of holdings8457
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateMay 9, 2016May 1, 2006
ESGYesNo
Advertisement
Exposure

Countries

AGNG
USA
55.01%
Switzerland
13.28%
Other
31.7%
IHE
USA
96.01%
Other
3.99%

Sectors

AGNG
Healthcare
90.38%
Finance
9.07%
Other
0.55%
IHE
Healthcare
99.92%
Other
0.08%
Advertisement

Diversification

AGNG

Total weight of top 15 holdings out of 15

47.54%
IHE

Total weight of top 15 holdings out of 15

84.53%

Top 15 holdings

Data as of June 30, 2026
AGNG
Novo Nordisk A/S
3.84%
Eli Lilly & Co.
3.82%
AbbVie, Inc.
3.57%
Edwards Lifesciences Corp.
3.42%
Welltower, Inc.
3.29%
Johnson & Johnson
3.19%
Merck & Co., Inc.
3.13%
Ventas, Inc.
3.11%
Roche Holding AG
3.05%
Amgen, Inc.
3.01%
Bristol Myers Squibb Co.
2.92%
Stryker Corp.
2.88%
UCB SA
2.81%
AstraZeneca PLC
2.76%
Medtronic Plc
2.73%
IHE
Johnson & Johnson
22.44%
Eli Lilly & Co.
22.25%
Merck & Co., Inc.
4.55%
Bristol Myers Squibb Co.
4.37%
Royalty Pharma Plc
4.33%
Viatris, Inc.
4.22%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.73%
Jazz Pharmaceuticals Plc
3.45%
Elanco Animal Health, Inc.
2.81%
Axsome Therapeutics, Inc.
2.41%
Corcept Therapeutics, Inc.
1.90%
Ligand Pharmaceuticals, Inc.
1.45%
Definium Therapeutics, Inc.
1.39%
Liquidia Corp.
1.28%
Frequently asked questions about AGNG and IHE

How have the AGNG and IHE ETFs performed in 2026?

As of July 30, 2026, AGNG is up 4.95% year-to-date (YTD), while IHE has returned 21.57%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: AGNG or IHE?

Year-to-date, the AGNG ETF saw +$13M in flows, compared to +$603M for IHE.

Which ETF is more volatile: AGNG or IHE?

Over the past year, AGNG had a volatility of 13.13%, while IHE experienced 18.02%.

Which ETF is bigger: AGNG or IHE?

As of July 30, 2026, AGNG holds $87.98 M in assets under management (AUM), while IHE manages $1.64 B.

What sectors do the AGNG and IHE ETFs invest in?

AGNG leans toward sectors like Healthcare and Finance. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the AGNG ETF and IHE ETF?

AGNG top holdings include Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: AGNG or IHE?

AGNG holds 84 securities with 47.54% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.53%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026